2020年6月至2023年11月COVID-19大流行期间加拿大队列研究中医护人员中SARS-CoV-2检测趋势

IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES
Nicole M Robertson, Brenda L Coleman, Robyn Harrison, Curtis Cooper, Jeya Nadarajah, Marek Smieja, Jeff Powis
{"title":"2020年6月至2023年11月COVID-19大流行期间加拿大队列研究中医护人员中SARS-CoV-2检测趋势","authors":"Nicole M Robertson, Brenda L Coleman, Robyn Harrison, Curtis Cooper, Jeya Nadarajah, Marek Smieja, Jeff Powis","doi":"10.1155/cjid/1858884","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> While testing healthcare workers (HCWs) for SARS-CoV-2 is important to reduce transmission within healthcare settings, understanding the self-reported patterns of testing is important for interpreting vaccine effectiveness and other COVID-19-related information. <b>Objective:</b> Using longitudinal data from the COVID-19 cohort study, this study described trends in SARS-CoV-2 testing among Canadian HCWs between June 2020 and November 2023. <b>Methods:</b> HCWs completed an illness report for each instance of SARS-CoV-2 testing and episodes of symptoms compatible with COVID-19 even if untested. Overall rates of testing among the participating cohort were calculated. Rates were stratified by province, reason for testing and COVID-19 vaccination status using 4-week intervals to smooth estimates. For episodes of symptomatic illness (only), the median time between symptom onset and first test was calculated, along with the percent of episodes initially receiving a negative result for SARS-CoV-2 that were reported as being retested. <b>Results:</b> Rates of testing for SARS-CoV-2 generally mirrored rates of hospitalisation for COVID-19 among Canadians. Rates of testing were highest during the Omicron BA.1 wave (11.9 participants tested at least once per 1000 person-days) and varied by province; vaccination status did not impact rates. The most common reason for testing was for symptoms. Testing for known exposure or routine reasons greatly decreased after the Omicron BA.1 wave. In participants who were tested for episodes of symptomatic illness, the median time between symptom onset and first test was 1 day (interquartile range 0-2). Reported retesting after an initial negative result remained low throughout the study period. <b>Conclusions:</b> Understanding testing behaviours is important for public health decision-making including the analysis and interpretation of case data and vaccine effectiveness studies. It can also highlight possible missed case-finding opportunities in healthcare settings.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2025 ","pages":"1858884"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12143943/pdf/","citationCount":"0","resultStr":"{\"title\":\"Trends in Testing for SARS-CoV-2 Among Healthcare Workers in a Canadian Cohort Study During the COVID-19 Pandemic, June 2020 to November 2023.\",\"authors\":\"Nicole M Robertson, Brenda L Coleman, Robyn Harrison, Curtis Cooper, Jeya Nadarajah, Marek Smieja, Jeff Powis\",\"doi\":\"10.1155/cjid/1858884\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> While testing healthcare workers (HCWs) for SARS-CoV-2 is important to reduce transmission within healthcare settings, understanding the self-reported patterns of testing is important for interpreting vaccine effectiveness and other COVID-19-related information. <b>Objective:</b> Using longitudinal data from the COVID-19 cohort study, this study described trends in SARS-CoV-2 testing among Canadian HCWs between June 2020 and November 2023. <b>Methods:</b> HCWs completed an illness report for each instance of SARS-CoV-2 testing and episodes of symptoms compatible with COVID-19 even if untested. Overall rates of testing among the participating cohort were calculated. Rates were stratified by province, reason for testing and COVID-19 vaccination status using 4-week intervals to smooth estimates. For episodes of symptomatic illness (only), the median time between symptom onset and first test was calculated, along with the percent of episodes initially receiving a negative result for SARS-CoV-2 that were reported as being retested. <b>Results:</b> Rates of testing for SARS-CoV-2 generally mirrored rates of hospitalisation for COVID-19 among Canadians. Rates of testing were highest during the Omicron BA.1 wave (11.9 participants tested at least once per 1000 person-days) and varied by province; vaccination status did not impact rates. The most common reason for testing was for symptoms. Testing for known exposure or routine reasons greatly decreased after the Omicron BA.1 wave. In participants who were tested for episodes of symptomatic illness, the median time between symptom onset and first test was 1 day (interquartile range 0-2). Reported retesting after an initial negative result remained low throughout the study period. <b>Conclusions:</b> Understanding testing behaviours is important for public health decision-making including the analysis and interpretation of case data and vaccine effectiveness studies. It can also highlight possible missed case-finding opportunities in healthcare settings.</p>\",\"PeriodicalId\":50715,\"journal\":{\"name\":\"Canadian Journal of Infectious Diseases & Medical Microbiology\",\"volume\":\"2025 \",\"pages\":\"1858884\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12143943/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Infectious Diseases & Medical Microbiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/cjid/1858884\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Infectious Diseases & Medical Microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/cjid/1858884","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景:虽然对卫生保健工作者进行SARS-CoV-2检测对于减少卫生保健机构内的传播很重要,但了解自我报告的检测模式对于解释疫苗有效性和其他与covid -19相关的信息也很重要。目的:利用COVID-19队列研究的纵向数据,本研究描述了2020年6月至2023年11月加拿大医护人员中SARS-CoV-2检测的趋势。方法:卫生保健工作者对每个SARS-CoV-2检测病例和与COVID-19相容的症状发作(即使未经检测)完成疾病报告。计算参与队列的总体检测率。发病率按省份、检测原因和COVID-19疫苗接种状况分层,间隔4周以平滑估计。对于(仅)有症状的疾病发作,计算了症状发作和第一次检测之间的中位数时间,以及最初获得SARS-CoV-2阴性结果的发作的百分比。结果:加拿大人的SARS-CoV-2检测率通常反映了COVID-19住院率。检测率在Omicron BA.1波期间最高(11.9名参与者每1000人日至少检测一次),且因省而异;疫苗接种状况不影响接种率。检查的最常见原因是症状。在欧米克隆BA.1波之后,已知暴露或常规原因的检测大大减少。在接受症状性疾病发作测试的参与者中,症状发作和首次测试之间的中位时间为1天(四分位数范围为0-2)。在最初的阴性结果后报告的重新检测在整个研究期间仍然很低。结论:了解检测行为对公共卫生决策非常重要,包括对病例数据和疫苗有效性研究的分析和解释。它还可以突出卫生保健环境中可能错过的病例发现机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Trends in Testing for SARS-CoV-2 Among Healthcare Workers in a Canadian Cohort Study During the COVID-19 Pandemic, June 2020 to November 2023.

Background: While testing healthcare workers (HCWs) for SARS-CoV-2 is important to reduce transmission within healthcare settings, understanding the self-reported patterns of testing is important for interpreting vaccine effectiveness and other COVID-19-related information. Objective: Using longitudinal data from the COVID-19 cohort study, this study described trends in SARS-CoV-2 testing among Canadian HCWs between June 2020 and November 2023. Methods: HCWs completed an illness report for each instance of SARS-CoV-2 testing and episodes of symptoms compatible with COVID-19 even if untested. Overall rates of testing among the participating cohort were calculated. Rates were stratified by province, reason for testing and COVID-19 vaccination status using 4-week intervals to smooth estimates. For episodes of symptomatic illness (only), the median time between symptom onset and first test was calculated, along with the percent of episodes initially receiving a negative result for SARS-CoV-2 that were reported as being retested. Results: Rates of testing for SARS-CoV-2 generally mirrored rates of hospitalisation for COVID-19 among Canadians. Rates of testing were highest during the Omicron BA.1 wave (11.9 participants tested at least once per 1000 person-days) and varied by province; vaccination status did not impact rates. The most common reason for testing was for symptoms. Testing for known exposure or routine reasons greatly decreased after the Omicron BA.1 wave. In participants who were tested for episodes of symptomatic illness, the median time between symptom onset and first test was 1 day (interquartile range 0-2). Reported retesting after an initial negative result remained low throughout the study period. Conclusions: Understanding testing behaviours is important for public health decision-making including the analysis and interpretation of case data and vaccine effectiveness studies. It can also highlight possible missed case-finding opportunities in healthcare settings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
108
审稿时长
>12 weeks
期刊介绍: Canadian Journal of Infectious Diseases and Medical Microbiology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to infectious diseases of bacterial, viral and parasitic origin. The journal welcomes articles describing research on pathogenesis, epidemiology of infection, diagnosis and treatment, antibiotics and resistance, and immunology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信